Latest 20 stories · newest Nov 4, 2026
CVS Health announced an intent to separate into a healthcare solutions company and CVS Pharmacy by 2028, aiming to execute on focus and value creation. The deal follows a strategic review and is expected to preserve an investment grade rating.
CVS Health reported third quarter 2026 total revenues of $108.4 billion, up 5.4% year-over-year, alongside GAAP diluted EPS of $1.68. The company raised its full-year 2026 guidance to reflect strong performance across its Health Care Benefits and Pharmacy & Consumer Wellness segments.
CVS Health announced the appointment of Teresa Heitsenrether and the departure of Larry Robbins from its Board. Robbins effective departure signals the end of a governance transition period.
CVS Health reported second-quarter 2026 revenues of $106.1 billion and raised its full-year GAAP adjusted EPS and cash flow guidance to reflect growth in the Health Care Benefits and Pharmacy & Consumer Wellness segments, despite caution regarding cost trends.
The same CVS feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/CVS/newsSTART FREE